Видео ютуба по тегу Philadelphia Chromosome-Positive

New approaches to upfront therapy in Ph+ ALL
New approaches to upfront therapy in Ph+ ALL
Evaluating the safety of TKI discontinuation in adult patients with Ph+ ALL not undergoing alloSCT
Evaluating the safety of TKI discontinuation in adult patients with Ph+ ALL not undergoing alloSCT
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Video Lecture)
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Video Lecture)
FDA D.I.S.C.O. Burst Edition: FDA approval of Scemblix (asciminib) for patients with Philadelphia...
FDA D.I.S.C.O. Burst Edition: FDA approval of Scemblix (asciminib) for patients with Philadelphia...
Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
imatinib
imatinib
An overview of trials investigating asciminib in the treatment of Ph+ CML
An overview of trials investigating asciminib in the treatment of Ph+ CML
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia and Treatment Options
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia and Treatment Options
Predictors of achieving undetectable BCR::ABL1 in patients with ALL
Predictors of achieving undetectable BCR::ABL1 in patients with ALL
How I treat newly diagnosed ALL
How I treat newly diagnosed ALL
Ponatinib and blinatumomab results in high rates of CMR and NGS MRD negativity in Ph-positive ALL
Ponatinib and blinatumomab results in high rates of CMR and NGS MRD negativity in Ph-positive ALL
The feasibility of chemotherapy-free regimens without allogeneic transplantation in MRD- Ph+ALL
The feasibility of chemotherapy-free regimens without allogeneic transplantation in MRD- Ph+ALL
Researchers identify a key molecular pathway in Philadelphia-positive acute lymphoblastic leukemia
Researchers identify a key molecular pathway in Philadelphia-positive acute lymphoblastic leukemia
Future treatment strategies for R/R Ph+ ALL
Future treatment strategies for R/R Ph+ ALL
Approaches to and the use of MRD in ALL
Approaches to and the use of MRD in ALL
Diagnostic and therapy of Ph-like acute lymphoblastic leukemia
Diagnostic and therapy of Ph-like acute lymphoblastic leukemia
The evolution of treatment of Ph+ ALL & Phase II study of blinatumomab and ponatinib in Ph+ ALL
The evolution of treatment of Ph+ ALL & Phase II study of blinatumomab and ponatinib in Ph+ ALL
Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL)